Tessa Straatmijer
7PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Apr 16, 2025
Obesity Is Associated with Inferior Clinical Treatment Outcomes in Inflammatory Bowel Disease: A Nationwide Dutch Registry Study.Dorien Oomkens, Zlatan Mujagic, Annemarie de Vries
|Mar 15, 2023
Ustekinumab Trough Concentrations Are Associated with Biochemical Outcomes in Patients with Crohn's Disease.Tessa Straatmijer, Vince B C Biemans, Dirk Jan A R Moes
|Feb 23, 2023
Letter: tricky reactions to switch back from subcutaneous to intravenous vedolizumab in inflammatory bowel disease patients-authors' reply.Adriaan Volkers, Tessa Straatmijer, Marjolijn Duijvestein
|Oct 25, 2022
Effectiveness and safety of tofacitinib for ulcerative colitis: two-year results of the ICC Registry.Tessa Straatmijer, Fiona D M van Schaik, Alexander G L Bodelier
|Jul 23, 2022
Real-world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases.Adriaan Volkers, Tessa Straatmijer, Marjolijn Duijvestein
|Jul 31, 2021
Letter: tofacitinib in treatment-refractory ulcerative colitis-a single centre real-world experience in Australia. Authors' reply.Vince B C Biemans, Tessa Straatmijer, Frank Hoentjen
Pageof 2
Frequent Collaborators
2 joint publications
Vince B C Biemans
2 joint publications
Adriaan Volkers
1 joint publications
Marieke Pierik
1 joint publications
Jeroen Maljaars
1 joint publications
Jurij Hanzel
1 joint publications
Frank Hoentjen
1 joint publications
Ad A van Bodegraven
1 joint publications
Dorien Oomkens
1 joint publications
Zlatan Mujagic
1 joint publications
Annemarie de Vries
